Skip to Content

Ph3 Iberdomide Maintenance Following Autologous Stem Cell Transplant in newly dx MM

Phase III Clinical Trial

A Phase 3 Two-stage Randomized Multi-center Controlled Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance) (IM048022)

Trial Number: 05827016
Trial Status: OPEN

Participating Locations